Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
gptkb:Edaravone
|
| gptkbp:approvedBy |
gptkb:Japan
gptkb:United_States |
| gptkbp:ATCCode |
N07XX13
|
| gptkbp:CASNumber |
89-25-8
|
| gptkbp:chemicalFormula |
C10H10N4O
|
| gptkbp:developedBy |
gptkb:Mitsubishi_Tanabe_Pharma
|
| gptkbp:hasSMILES |
C1=CC(=CC=C1C(=O)N2C=NC=N2)N
|
| https://www.w3.org/2000/01/rdf-schema#label |
MCI-186
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
free radical scavenger
|
| gptkbp:molecularWeight |
174.21 g/mol
|
| gptkbp:PubChem_CID |
4021
CHEMBL1201192 |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
gptkb:eczema
headache dermatitis contusion gait disturbance |
| gptkbp:UNII |
QX9Y1Z8K5S
|
| gptkbp:usedFor |
treatment of acute ischemic stroke
treatment of amyotrophic lateral sclerosis |
| gptkbp:bfsParent |
gptkb:Radicava
|
| gptkbp:bfsLayer |
6
|